Genetic ‘Balance’ May Influence Response to Cancer Treatment
The chromosomal “balance” of normal and abnormal versions of the cancer-driving gene KRAS affects the response to targeted treatments.
University of California San Francisco
Give to UCSFThe chromosomal “balance” of normal and abnormal versions of the cancer-driving gene KRAS affects the response to targeted treatments.
Scalp cooling can lessen some chemotherapy-induced hair loss – one of the most devastating hallmarks of cancer – in certain breast cancer patients, according to a new multicenter study from UCSF, Weill Cornell Medicine and three other medical centers.
Women whose breasts are composed largely of glandular tissue, rather than fat, have an amplified risk of breast cancer, which exceeds the impact of other widely known risks on a population level.
A new study identified genetic predictors of normal prostate-specific antigen (PSA) levels in healthy men, which could be used to improve the accuracy of PSA-based prostate cancer screening tests.
E-cigarettes – thought by some to be responsible for a decline in youth cigarette smoking – are actually attracting a new population of adolescents who might not otherwise have smoked tobacco products.
New research has found that successful cancer immunotherapy appears to depend on whether the treatment can trigger a system-wide immune response, rather than just a local response within the tumor itself.
UC San Francisco scientists have formed an innovative research alliance with three global pharmaceutical companies.
UCSF researchers have taken a major step toward understanding the function of the tens of thousands of human genes that do not code for proteins, a phenomenon considered one of the key remaining mysteries of the human genome.
To give you a bit of scientific motivation, UCSF gathered some of the latest research behind the most popular health-related New Year’s resolutions that attest to why it really is good for your body to see them through.
Stories about sensory processing disorder, videos about “zombie” cancer cells, and news about the effects of caffeine and alcohol on the heart were among the topics that most engaged our readers in 2016.
Education by community-based non-professional health workers significantly increased colorectal cancer screening rates among mostly non-English-speaking, older Chinese-Americans in San Francisco.
Nearly half of the patients in a safety net health system who had an abnormal stool-based screening test for colorectal cancer failed to receive the recommended colonoscopy within a year.
UCSF researchers have developed a new variety of targeting system for chemotherapy drugs based on the unusually high free iron content of many cancer cells.
California adolescents perceive smoking cigarettes to be riskier – and less socially acceptable – than they did a dozen years ago.
UCSF researchers found a way to pause the development of early mouse embryos for up to a month in the lab, a finding with implications for assisted reproduction, regenerative medicine, aging and cancer.
According to a new study led by UCSF scientists, lung cancer’s ability to spread may often be due to the inactivation of a single protective protein within tumor cells.
A group that includes UCSF, the City and County of San Francisco, and health care and community organizations has launched the San Francisco Cancer Initiative, a major public health effort to reduce cancer in San Francisco.
Next-generation sequencing for patients at UCSF Medical Center is prompting changes in brain tumor diagnoses for some children and a retooling of treatment plans in many cases.
UCSF Health and John Muir Health are augmenting their growing collaboration through a plan to expand world-class, compassionate cancer care.
A team of researchers led by UCSF scientists has identified a new drug target for triple-negative breast cancer.
Watch the highlights from some of UCSF's foremost scientists who participated in the Dreamforce conference this year.
The UCSF Helen Diller Family Comprehensive Cancer Center is one of only 12 academic centers in the U.S. joining a large national precision medicine study that aims to improve survival for pancreatic cancer patients.
The National Institutes of Health has awarded grants to seven UCSF scientists to pursue innovative approaches to major contemporary challenges in biomedical research.